{"id":52129,"date":"2025-12-29T11:42:47","date_gmt":"2025-12-29T03:42:47","guid":{"rendered":"https:\/\/flcube.com\/?p=52129"},"modified":"2025-12-29T11:42:48","modified_gmt":"2025-12-29T03:42:48","slug":"hybio-pharmaceutical-dr-reddys-forge-peptide-api-partnership","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=52129","title":{"rendered":"Hybio Pharmaceutical, Dr. Reddy\u2019s Forge Peptide API Partnership"},"content":{"rendered":"\n<p><strong>Hybio Pharmaceutical<\/strong> and <strong>Dr. Reddy\u2019s Laboratories<\/strong> entered a strategic partnership, signing a <strong>non\u2011binding Term Sheet<\/strong> to collaborate on <strong>peptide Active Pharmaceutical Ingredients (APIs)<\/strong> and related formulations. Hybio will serve as Dr. Reddy\u2019s <strong>preferred API development and supply partner<\/strong>, with preferred or semi\u2011exclusive arrangements for specific products based on minimum purchase volume commitments. The partnership also explores generics, oligonucleotides, and other emerging therapeutic sectors.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-transaction-overview\">Transaction Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Component<\/th><th>Details<\/th><\/tr><\/thead><tbody><tr><td><strong>Partners<\/strong><\/td><td>Hybio Pharmaceutical + Dr. Reddy\u2019s Laboratories<\/td><\/tr><tr><td><strong>Agreement Type<\/strong><\/td><td>Non\u2011binding Term Sheet<\/td><\/tr><tr><td><strong>Focus<\/strong><\/td><td>Peptide APIs and related formulations<\/td><\/tr><tr><td><strong>Structure<\/strong><\/td><td>Preferred API development and supply partnership<\/td><\/tr><tr><td><strong>Exclusivity<\/strong><\/td><td>Preferred or semi\u2011exclusive for specific products<\/td><\/tr><tr><td><strong>Commitments<\/strong><\/td><td>Minimum purchase volume requirements<\/td><\/tr><tr><td><strong>Geographic Scope<\/strong><\/td><td>Global cooperation<\/td><\/tr><tr><td><strong>Expansion Areas<\/strong><\/td><td>Generics, oligonucleotides, other emerging sectors<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-implications\">Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>For Hybio:<\/strong> <strong>Preferred supplier status<\/strong> with a global pharma leader validates its peptide platform; <strong>minimum volume commitments<\/strong> provide revenue predictability; <strong>long\u2011term partnership<\/strong> secures capacity utilization; <strong>oligonucleotide expansion<\/strong> opens high\u2011growth RNA therapeutics market.<\/li>\n\n\n\n<li><strong>For Dr. Reddy\u2019s:<\/strong> <strong>Secures supply chain<\/strong> for peptide formulations; <strong>preferred access<\/strong> to Hybio\u2019s manufacturing expertise reduces development risk; <strong>semi\u2011exclusive arrangements<\/strong> create competitive moat in select products; <strong>geographic diversification<\/strong> strengthens global generics portfolio.<\/li>\n\n\n\n<li><strong>For Market:<\/strong> Demonstrates <strong>strategic shift<\/strong> toward <strong>API\u2011formulation vertical integration<\/strong>; <strong>peptide and oligonucleotide focus<\/strong> aligns with <strong>biologics and RNA therapeutics growth<\/strong>; <strong>Indian\u2011Chinese partnership<\/strong> model optimizes cost and innovation synergies.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding partnership expansion, minimum volume commitments, and market penetration. Actual results may differ due to regulatory changes, competitive dynamics, or execution challenges.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hybio Pharmaceutical and Dr. Reddy\u2019s Laboratories entered a strategic partnership, signing a non\u2011binding Term Sheet&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[762,287],"class_list":["post-52129","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-dr-reddys-laboratories","tag-hybio-pharmaceutical"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Hybio Pharmaceutical, Dr. Reddy\u2019s Forge Peptide API Partnership - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Hybio Pharmaceutical and Dr. Reddy\u2019s Laboratories entered a strategic partnership, signing a non\u2011binding Term Sheet to collaborate on peptide Active Pharmaceutical Ingredients (APIs) and related formulations. Hybio will serve as Dr. Reddy\u2019s preferred API development and supply partner, with preferred or semi\u2011exclusive arrangements for specific products based on minimum purchase volume commitments. The partnership also explores generics, oligonucleotides, and other emerging therapeutic sectors.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=52129\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hybio Pharmaceutical, Dr. Reddy\u2019s Forge Peptide API Partnership\" \/>\n<meta property=\"og:description\" content=\"Hybio Pharmaceutical and Dr. Reddy\u2019s Laboratories entered a strategic partnership, signing a non\u2011binding Term Sheet to collaborate on peptide Active Pharmaceutical Ingredients (APIs) and related formulations. Hybio will serve as Dr. Reddy\u2019s preferred API development and supply partner, with preferred or semi\u2011exclusive arrangements for specific products based on minimum purchase volume commitments. The partnership also explores generics, oligonucleotides, and other emerging therapeutic sectors.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=52129\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-29T03:42:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-29T03:42:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52129#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52129\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Hybio Pharmaceutical, Dr. Reddy\u2019s Forge Peptide API Partnership\",\"datePublished\":\"2025-12-29T03:42:47+00:00\",\"dateModified\":\"2025-12-29T03:42:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52129\"},\"wordCount\":266,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Dr. Reddy's Laboratories\",\"Hybio Pharmaceutical\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=52129#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52129\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=52129\",\"name\":\"Hybio Pharmaceutical, Dr. Reddy\u2019s Forge Peptide API Partnership - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2025-12-29T03:42:47+00:00\",\"dateModified\":\"2025-12-29T03:42:48+00:00\",\"description\":\"Hybio Pharmaceutical and Dr. Reddy\u2019s Laboratories entered a strategic partnership, signing a non\u2011binding Term Sheet to collaborate on peptide Active Pharmaceutical Ingredients (APIs) and related formulations. Hybio will serve as Dr. Reddy\u2019s preferred API development and supply partner, with preferred or semi\u2011exclusive arrangements for specific products based on minimum purchase volume commitments. The partnership also explores generics, oligonucleotides, and other emerging therapeutic sectors.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52129#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=52129\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52129#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hybio Pharmaceutical, Dr. Reddy\u2019s Forge Peptide API Partnership\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Hybio Pharmaceutical, Dr. Reddy\u2019s Forge Peptide API Partnership - Insight, China&#039;s Pharmaceutical Industry","description":"Hybio Pharmaceutical and Dr. Reddy\u2019s Laboratories entered a strategic partnership, signing a non\u2011binding Term Sheet to collaborate on peptide Active Pharmaceutical Ingredients (APIs) and related formulations. Hybio will serve as Dr. Reddy\u2019s preferred API development and supply partner, with preferred or semi\u2011exclusive arrangements for specific products based on minimum purchase volume commitments. The partnership also explores generics, oligonucleotides, and other emerging therapeutic sectors.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=52129","og_locale":"en_US","og_type":"article","og_title":"Hybio Pharmaceutical, Dr. Reddy\u2019s Forge Peptide API Partnership","og_description":"Hybio Pharmaceutical and Dr. Reddy\u2019s Laboratories entered a strategic partnership, signing a non\u2011binding Term Sheet to collaborate on peptide Active Pharmaceutical Ingredients (APIs) and related formulations. Hybio will serve as Dr. Reddy\u2019s preferred API development and supply partner, with preferred or semi\u2011exclusive arrangements for specific products based on minimum purchase volume commitments. The partnership also explores generics, oligonucleotides, and other emerging therapeutic sectors.","og_url":"https:\/\/flcube.com\/?p=52129","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-12-29T03:42:47+00:00","article_modified_time":"2025-12-29T03:42:48+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=52129#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=52129"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Hybio Pharmaceutical, Dr. Reddy\u2019s Forge Peptide API Partnership","datePublished":"2025-12-29T03:42:47+00:00","dateModified":"2025-12-29T03:42:48+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=52129"},"wordCount":266,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Dr. Reddy's Laboratories","Hybio Pharmaceutical"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=52129#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=52129","url":"https:\/\/flcube.com\/?p=52129","name":"Hybio Pharmaceutical, Dr. Reddy\u2019s Forge Peptide API Partnership - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2025-12-29T03:42:47+00:00","dateModified":"2025-12-29T03:42:48+00:00","description":"Hybio Pharmaceutical and Dr. Reddy\u2019s Laboratories entered a strategic partnership, signing a non\u2011binding Term Sheet to collaborate on peptide Active Pharmaceutical Ingredients (APIs) and related formulations. Hybio will serve as Dr. Reddy\u2019s preferred API development and supply partner, with preferred or semi\u2011exclusive arrangements for specific products based on minimum purchase volume commitments. The partnership also explores generics, oligonucleotides, and other emerging therapeutic sectors.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=52129#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=52129"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=52129#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Hybio Pharmaceutical, Dr. Reddy\u2019s Forge Peptide API Partnership"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=52129"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52129\/revisions"}],"predecessor-version":[{"id":52130,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52129\/revisions\/52130"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=52129"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=52129"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=52129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}